AIM ImmunoTech Inc.
AIM
$0.1213
$0.00131.08%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.20M | 10.06M | 10.94M | 13.07M | 22.43M |
Total Receivables | -- | -- | -- | 1.18M | 48.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 368.00K | 300.00K | 364.00K | 302.00K | 263.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 7.57M | 10.36M | 11.31M | 14.56M | 22.74M |
|
|||||
Total Current Assets | 7.57M | 10.36M | 11.31M | 14.56M | 22.74M |
Net Property, Plant & Equipment | 770.00K | 809.00K | 881.00K | 824.00K | 863.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.53M | 2.49M | 2.31M | 2.31M | 2.15M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.72M | 2.05M | 1.69M | 1.69M | 2.10M |
Total Assets | 13.59M | 15.72M | 16.19M | 19.38M | 27.86M |
|
|||||
Total Accounts Payable | 6.26M | 5.46M | 6.57M | 6.44M | 2.79M |
Total Accrued Expenses | 1.01M | 799.00K | 1.45M | 1.99M | 1.72M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.83M | 2.59M | 1.86M | 223.00K | 207.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 10.10M | 8.84M | 9.88M | 8.65M | 4.72M |
|
|||||
Total Current Liabilities | 10.10M | 8.84M | 9.88M | 8.65M | 4.72M |
Long-Term Debt | 139.00K | 283.00K | 950.00K | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 437.00K | 488.00K | 537.00K | 495.00K | 543.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 10.68M | 9.61M | 11.36M | 9.15M | 5.26M |
|
|||||
Common Stock & APIC | 423.77M | 423.26M | 419.46M | 419.05M | 418.84M |
Retained Earnings | -420.86M | -417.16M | -415.33M | -409.51M | -396.93M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 2.91M | 6.10M | 4.14M | 9.55M | 21.91M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 689.00K | 689.00K | 690.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 689.00K | 689.00K | 690.00K |
|
|||||
Total Common Equity | 2.91M | 6.10M | 4.14M | 9.55M | 21.91M |
Total Preferred Equity | -- | -- | 689.00K | 689.00K | 690.00K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 2.91M | 6.10M | 4.83M | 10.23M | 22.60M |
|